Hardoak you are right, today's announcement is what we have needed and your reminder about the AGM points to the company direction quite clearly being delivered. Mind you the Shorters had a ball for many months somewhat because management appeared to be reluctant to report on lilly's Axiron results in the U.S, such as becoming no 2, reduced rebates and other product plans etc etc. Indeed without the regular musings and encouragement of h.c. posters such as you and other regulars our knowledge about Acrux would be much less. My request to management is please continue with the results that Hardoak has reminded us about and publish regular business activity updates, you have created a great story keep communicating it. You only have to see that today will be imprinted into the memory of the "Shorting brokers" for some time.
ACR Price at posting:
$3.90 Sentiment: Buy Disclosure: Held
